Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
Want to see HK:3737 full AI Analyst Report?
Total Valuation
Zhongzhi Pharmaceutical Holdings Limited has a market cap or net worth of HK$669.13M. The enterprise value is HK$605.14M.
Market CapHK$669.13M
Enterprise ValueHK$605.14M
Share Statistics
Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding863,600,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhongzhi Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.34%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.34%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee674.23K
Profits Per Employee6.54K
Employee Count2,577
Asset Turnover0.95
Inventory Turnover2.84
Valuation Ratios
The current PE Ratio of Zhongzhi Pharmaceutical Holdings Limited is 25.1. Zhongzhi Pharmaceutical Holdings Limited’s PEG ratio is -0.31.
PE Ratio25.1
PS Ratio0.25
PB Ratio0.40
Price to Fair Value0.40
Price to FCF6.22
Price to Operating Cash Flow7.16
PEG Ratio-0.31
Income Statement
In the last 12 months, Zhongzhi Pharmaceutical Holdings Limited had revenue of 1.74B and earned 17.29M in profits. Earnings per share was 0.02.
Revenue1.74B
Gross Profit940.25M
Operating Income4.93M
Pretax Income18.99M
Net Income17.29M
EBITDA55.28M
Earnings Per Share (EPS)0.02
Cash Flow
In the last 12 months, operating cash flow was 81.48M and capital expenditures -35.33M, giving a free cash flow of 46.15M billion.
Operating Cash Flow81.48M
Free Cash Flow46.15M
Free Cash Flow per Share0.05
Dividends & Yields
Zhongzhi Pharmaceutical Holdings Limited pays an annual dividend of HK$0.05, resulting in a dividend yield of 9.43%
Dividend Per ShareHK$0.05
Dividend Yield9.43%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.07
52-Week Price Change-7.06%
50-Day Moving Average0.83
200-Day Moving Average0.73
Relative Strength Index (RSI)44.43
Average Volume (3m)412.77K
Important Dates
Zhongzhi Pharmaceutical Holdings Limited upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Zhongzhi Pharmaceutical Holdings Limited as a current ratio of 1.60, with Debt / Equity ratio of 20.73%
Current Ratio1.60
Quick Ratio1.15
Debt to Market Cap0.41
Net Debt to EBITDA0.47
Interest Coverage Ratio0.94
Taxes
In the past 12 months, Zhongzhi Pharmaceutical Holdings Limited has paid 1.28M in taxes.
Income Tax1.28M
Effective Tax Rate0.07
Enterprise Valuation
Zhongzhi Pharmaceutical Holdings Limited EV to EBITDA ratio is 8.34, with an EV/FCF ratio of 6.60.
EV to Sales0.27
EV to EBITDA8.34
EV to Free Cash Flow6.60
EV to Operating Cash Flow4.42
Balance Sheet
Zhongzhi Pharmaceutical Holdings Limited has HK$200.89M in cash and marketable securities with HK$227.02M in debt, giving a net cash position of -HK$26.13M billion.
Cash & Marketable SecuritiesHK$200.89M
Total DebtHK$227.02M
Net Cash-HK$26.13M
Net Cash Per Share-HK$0.03
Tangible Book Value Per ShareHK$1.26
Margins
Gross margin is 54.12%, with operating margin of 0.28%, and net profit margin of 1.00%.
Gross Margin54.12%
Operating Margin0.28%
Pretax Margin1.09%
Net Profit Margin1.00%
EBITDA Margin3.18%
EBIT Margin-0.10%
Analyst Forecast
The average price target for Zhongzhi Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-21.54%
EPS Growth Forecast-81.79%